GSTM2 (−1.354 FC, p = 0.0041), CKMT2 (−1.499 FC, p = 0.0172), and MB (−1.727 FC, p = 0.0027) expression levels were reduced after HFD + Atorv and HFD + W treatments (−1.326 FC; p = 0.0047, −1.418 FC; p = 0.0116, and −1.512 FC; p = 0.0199, respectively) when compared to the levels after HFD treatment; however, GSTM2 (1.386 FC, p = 0.0034), CKMT2 (1.532 FC, p = 0.0015), and MB (1.609 FC, p = 0.0100) expression levels were increased after HFD treatment when compared to the levels after SCD treatment. Here, GSTM2 is linked to Schnyder corneal dystrophy.